Evidence map›Paper›PMID 29988701›Full record

ReviewImmunoTargets and therapy2018

Multiple effects of CD40-CD40L axis in immunity against infection and cancer.

Anjuman Ara, Khawaja Ashfaque Ahmed, Jim Xiang

Abstract readReview
In one paragraph

Review in ImmunoTargets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anjuman AraCancer Research Cluster, Saskatchewan Cancer Agency, Saskatoon, Saskatchewan, Canada, jim.xiang@usask.ca.
Khawaja Ashfaque AhmedCancer Research Cluster, Saskatchewan Cancer Agency, Saskatoon, Saskatchewan, Canada, jim.xiang@usask.ca.
Jim XiangCancer Research Cluster, Saskatchewan Cancer Agency, Saskatoon, Saskatchewan, Canada, jim.xiang@usask.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD8

Indexed as

CD40–CD40Lcostimulatory signalsCTL exhaustionmTORC1T-cell immunitytrogocytosis

Identifiers

PMID29988701
PMCPMC6029590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.